TARS — 3 insiders, all selling
Tarsus Pharmaceuticals, Inc. · Materials · ISO week 2026-W36 (2026-09-01 → 2026-09-04)
3Distinct insiders
11Transactions
−$4.2MTotal reported value
5Source filings
Members
| Insider | Role | Txns | Reported value |
|---|---|---|---|
| Lin Elizabeth Yeu | Chief Medical Officer | 7 | $2.1M |
| Azamian Bobak R. | President/CEO and Board Chair | 3 | $1.7M |
| Neervannan Seshadri | Chief Operating Officer | 1 | $388k |
Timeline
2026-09-01
- − Lin Elizabeth Yeu Chief Medical Officer S 4,601 sh @ $73.86 = $340k 0001842190-26-000009
2026-09-02
- − Lin Elizabeth Yeu Chief Medical Officer S 5,387 sh @ $80.00 = $431k 0001842190-26-000009
- − Lin Elizabeth Yeu Chief Medical Officer S 1,590 sh @ $80.00 = $127k 0001842190-26-000009
- − Azamian Bobak R. President/CEO and Board Chair S 10,000 sh @ $80.06 = $801k 0001827672-26-000011
2026-09-04
- − Lin Elizabeth Yeu Chief Medical Officer S 5,387 sh @ $85.00 = $458k 0001842190-26-000011
- − Lin Elizabeth Yeu Chief Medical Officer S 5,386 sh @ $90.00 = $485k 0001842190-26-000011
- − Lin Elizabeth Yeu Chief Medical Officer S 1,590 sh @ $85.00 = $135k 0001842190-26-000011
- − Lin Elizabeth Yeu Chief Medical Officer S 1,590 sh @ $90.00 = $143k 0001842190-26-000011
- − Azamian Bobak R. President/CEO and Board Chair S 7,100 sh @ $90.27 = $641k 0001827672-26-000013
- − Azamian Bobak R. President/CEO and Board Chair S 2,900 sh @ $91.27 = $265k 0001827672-26-000013
- − Neervannan Seshadri Chief Operating Officer S 4,564 sh @ $85.00 = $388k 0001827584-26-000013